Genetic variation in iron metabolism is associated with neuropathic pain and pain severity in HIV-infected patients on antiretroviral therapy

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Kallianpur, Asha R ^a,b   Jia, Peilin ^c   Ellis, Ronald J ^d   Zhao, Zhongming ^c   Bloss, Cinnamon ^e   Wen, Wanqing ^c   Marra, Christina M ^f   Hulgan, Todd ^c   Simpson, David M ^g   Morgello, Susan ^g   McArthur, Justin C ^h   Clifford, David B ⁱ   Collier, Ann C ^f   Gelman, Benjamin B ^j   McCutchan, J Allen ^k   Franklin, Donald ^l   Samuels, David C ^m   Rosario, Debralee ^l   Holzinger, Emily ^m   Murdock, Deborah G ^m   Letendre, Scott ^k   Grant, Igor ^l   more..

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e SCRIPPS TRANSLATIONAL SCIENCE INSTITUTE   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j University of Texas Medical Branch School of Medicine   (United States)

^k UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 6; IRON REGULATORY PROTEIN 1; ANTIRETROVIRUS AGENT; IRON;

ANALYTIC METHOD; ARTICLE; BLACK PERSON; CAUCASIAN; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISTAL NEUROPATHIC PAIN; FEMALE; GENETIC VARIABILITY; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IRON METABOLISM; IRON TRANSPORT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; NEUROPATHIC PAIN; OBSERVATIONAL STUDY; PAIN SEVERITY; PERIPHERAL NEUROPATHY; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION; SENSORY NEUROPATHY; SINGLE NUCLEOTIDE POLYMORPHISM; STRUCTURED INTERVIEW; ADULT; AGED; GENE LINKAGE DISEQUILIBRIUM; GENETICS; HIV INFECTIONS; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEURALGIA; PATHOPHYSIOLOGY; YOUNG ADULT;

ADULT; AGED; ANTI-RETROVIRAL AGENTS; FEMALE; GENETIC VARIATION; GENOTYPE; HIV INFECTIONS; HUMANS; IRON; IRON REGULATORY PROTEIN 1; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEURALGIA; YOUNG ADULT;

EID: 84940240564     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103123     Document Type: Article

References (85)

1. Ellis RJ, Rosario D, Clifford DB, McArthur JC, Simpson D, et al. (2010) Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study. Arch Neurol 67: 552-558.
2. Kallianpur AR, Hulgan T (2009) Pharmacogenetics of nucleoside reverse-transcriptase inhibitor-associated peripheral neuropathy. Pharmacogenomics 10: 623-637.
3. Hitchcock SA, Meyer HP, Gwyther E (2008) Neuropathic pain in AIDS patients prior to antiretroviral therapy. S Afr Med J 98: 889-892.
4. Apostolova N, Blas-Garcia A, Esplugues JV (2011) Mitochondrial interference by anti-HIV drugs: mechanisms beyond Pol-gamma inhibition. Trends in Pharmacological Sciences 32: 715-725.
5. Hulgan T, Haas DW, Haines JL, Ritchie MD, Robbins GK, et al. (2005) Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study. AIDS 19: 1341-1349. (Pubitemid 41800669)
6. Hulgan T, Tebas P, Canter JA, Mulligan K, Haas DW, et al. (2008) Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapy. J Infect Dis 197: 858-866. (Pubitemid 351417009)
7. Kamerman PR, Moss PJ, Weber J, Wallace VC, Rice AS, et al. (2012) Pathogenesis of HIV-associated sensory neuropathy: evidence from in vivo and in vitro experimental models. J Peripher Nerv Syst 17: 19-31.
8. Keswani SC, Jack C, Zhou C, Hoke A (2006) Establishment of a rodent model of HIV-associated sensory neuropathy. J Neurosci 26: 10299-10304. (Pubitemid 44527423)
9. Ellis RJ, Marquie-Beck J, Delaney P, Alexander T, Clifford DB, et al. (2008) Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy. Ann Neurol 64: 566-572.
10. Robinson-Papp J, Morgello S, Vaida F, Fitzsimons C, Simpson DM, et al. (2010) Association of self-reported painful symptoms with clinical and neurophysiologic signs in HIV-associated sensory neuropathy. Pain 151: 732-736.
11. Lucey BP, Clifford DB, Creighton J, Edwards RR, McArthur JC, et al. (2011) Relationship of depression and catastrophizing to pain, disability, and medication adherence in patients with HIV-associated sensory neuropathy. Aids Care-Psychological and Socio-Medical Aspects of Aids/Hiv 23: 921-928.
12. Phillips TJ, Cherry CL, Cox S, Marshall SJ, Rice AS (2010) Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials. PLoS One 5: e14433.
13. Chetty S, Baalbergen E, Bhigjee AI, Kamerman P, Ouma J, et al. (2012) Clinical practice guidelines for management of neuropathic pain: expert panel recommendations for South Africa. Samj South African Medical Journal 102: 312-325.
14. Derry S, Moore RA (2012) Topical capsaicin (low concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev 9: CD010111.
15. Evans SR, Simpson DM, Kitch DW, King A, Clifford DB, et al. (2007) A Randomized Trial Evaluating Prosaptide (TM) for HIV-Associated Sensory Neuropathies: Use of an Electronic Diary to Record Neuropathic Pain. PLoS One 2: e551.
16. Keltner JR, Vaida F, Ellis RJ, Moeller-Bertram T, Fitzsimmons C, et al. (2012) Health-related quality of life 'well-being' in HIV distal neuropathic pain is more strongly associated with depression severity than with pain intensity. Psychosomatics 53: 380-386.
17. Fellows RP, Byrd DA, Elliott K, Robinson-Papp J, Mindt MR, et al. (2012) Distal sensory polyneuropathy is associated with neuropsychological test performance among persons with HIV. J Int Neuropsychol Soc 18: 898-907.
18. Davis L, Evans S, Fishman B, Haley A, Spielman LA (2004) Predictors of attrition in HIV-positive subjects with peripheral neuropathic pain. Aids Care-Psychological and Socio-Medical Aspects of Aids/Hiv 16: 395-402.
19. Oshinaike O, Akinbami A, Ojo O, Ogbera A, Okubadejo N, et al. (2012) Influence of Age and Neurotoxic HAART Use on Frequency of HIV Sensory Neuropathy. AIDS Res Treat 2012: 961510.
20. Pahuja M, Grobler A, Glesby MJ, Karim F, Parker G, et al. (2012) Effects of a reduced dose of stavudine on the incidence and severity of peripheral neuropathy in HIV-infected adults in South Africa. Antiviral Therapy 17: 737-743.
21. Backonja M, Woolf CJ (2010) Future directions in neuropathic pain therapy: closing the translational loop. Oncologist 15 Suppl 2: 24-29.
22. Maag R, Baron R (2006) Neuropathic pain: translational research and impact for patient care. Curr Pain Headache Rep 10: 191-198. (Pubitemid 43933175)
23. Max MB, Stewart WF (2008) The molecular epidemiology of pain: a new discipline for drug discovery. Nature Reviews Drug Discovery 7: 647-658.
24. Galy B, Ferring-Appel D, Sauer SW, Kaden S, Lyoumi S, et al. (2010) Iron regulatory proteins secure mitochondrial iron sufficiency and function. Cell Metab 12: 194-201.
25. Millecamps S, Julien JP (2013) Axonal transport deficits and neurodegenerative diseases. Nature Reviews Neuroscience 14: 161-176.
26. Sheftel AD, Lill R (2009) The power plant of the cell is also a smithy: the emerging role of mitochondria in cellular iron homeostasis. Ann Med 41: 82-99.
27. Drakesmith H, Prentice AM (2012) Hepcidin and the Iron-Infection Axis. Science 338: 768-772.
28. Wu X, Yung LM, Cheng WH, Yu PB, Babitt JL, et al. (2012) Hepcidin regulation by BMP signaling in macrophages is lipopolysaccharide dependent. PLoS One 7: e44622.
29. Zhang X, Rovin BH (2013) Beyond anemia: hepcidin, monocytes and inflammation. Biol Chem 394: 231-238.
30. Johnson EE, Sandgren A, Cherayil BJ, Murray M, Wessling-Resnick M (2010) Role of ferroportin in macrophage-mediated immunity. Infect Immun 78: 5099-5106.
31. Kallianpur AR, Hulgan T, Canter JA, Ritchie MD, Haines JL, et al. (2006) Hemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapy. AIDS 20: 1503-1513. (Pubitemid 44100211)
32. Bulaj ZJ, Griffen LM, Jorde LB, Edwards CQ, Kushner JP (1996) Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med 335: 1799-1805. (Pubitemid 26412398)
33. Holzinger ER, Hulgan T, Ellis RJ, Samuels DC, Ritchie MD, et al. (2012) Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER. J Neurovirol 18: 511-520.
34. Grady BJ, Dudek S, Ritchie MD (2009) Finding Unique Filter Sets in PLATO: Preparation for Efficient Interaction Analysis. Genetic Epidemiology 33: 788-788.
35. Kumar KR, Djarmati-Westenberger A, Grunewald A (2011) Genetics of Parkinson's disease. Semin Neurol 31: 433-440.
36. Reich DE, Lander ES (2001) On the allelic spectrum of human disease. Trends Genet 17: 502-510. (Pubitemid 32763048)
37. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. American Journal of Human Genetics 81: 559-575. (Pubitemid 47330214)
38. Jia P, Wang L, Fanous AH, Chen X, Kendler KS, et al. (2012) A bias-reducing pathway enrichment analysis of genome-wide association data confirmed association of the MHC region with schizophrenia. J Med Genet 49: 96-103.
39. Bush WS, Moore JH (2012) Chapter 11: Genome-wide association studies. PLoS Comput Biol 8: e1002822.
40. Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, et al. (2010) LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 26: 2336-2337.
41. Cano A, Mayo A, Ventimiglia M (2006) Coping, pain severity, interference, and disability: the potential mediating and moderating roles of race and education. Journal of Pain 7: 459-468. (Pubitemid 43929428)
42. Wandner LD, Scipio CD, Hirsh AT, Torres CA, Robinson ME (2012) The perception of pain in others: how gender, race, and age influence pain expectations. Journal of Pain 13: 220-227.
43. Lorber M, Haddad S (2013) Hypersensitivity and desensitization to darunavir in a case of HIV infection with triple-class drug resistance: case description and review of the literature. J Int Assoc Provid AIDS Care 12: 378-379.
44. Kranick SM, Nath A (2012) Neurologic complications of HIV-1 infection and its treatment in the era of antiretroviral therapy. Continuum (Minneap Minn) 18: 1319-1337.
45. Boelaert JR, Weinberg GA, Weinberg ED (1996) Altered iron metabolism in HIV infection: mechanisms, possible consequences, and proposals for management. Infect Agents Dis 5: 36-46. (Pubitemid 26038608)
46. Drakesmith H, Chen N, Ledermann H, Screaton G, Townsend A, et al. (2005) HIV-1 Nef down-regulates the hemochromatosis protein HFE, manipulating cellular iron homeostasis. Proc Natl Acad Sci U S A 102: 11017-11022. (Pubitemid 41105985)
47. Finberg KE (2013) Regulation of systemic iron homeostasis. Curr Opin Hematol 20: 208-214.
48. Bentley AJ, Rosman KD, Mitchell D (2007) Can the sensory symptoms of restless legs syndrome be assessed using a qualitative pain questionnaire? Clin J Pain 23: 62-66.
49. Gemignani F, Vitetta F, Brindani F, Contini M, Negrotti A (2013) Painful polyneuropathy associated with restless legs syndrome. Clinical features and sensory profile. Sleep Med 14: 79-84.
50. Connor JR, Ponnuru P, Wang XS, Patton SM, Allen RP, et al. (2011) Profile of altered brain iron acquisition in restless legs syndrome. Brain 134: 959-968.
51. Patton SM, Ponnuru P, Snyder AM, Podskalny GD, Connor JR (2011) Hypoxia-inducible factor pathway activation in restless legs syndrome patients. Eur J Neurol 18: 1329-1335.
52. Hare D, Ayton S, Bush A, Lei P (2013) A delicate balance: Iron metabolism and diseases of the brain. Front Aging Neurosci 5: 34.
53. Dowling P, Klinker F, Amaya F, Paulus W, Liebetanz D (2009) Iron-deficiency sensitizes mice to acute pain stimuli and formalin-induced nociception. J Nutr 139: 2087-2092.
54. Dubovy P (2011) Wallerian degeneration and peripheral nerve conditions for both axonal regeneration and neuropathic pain induction. Ann Anat 193: 267-275.
55. Gille G, Reichmann H (2011) Iron-dependent functions of mitochondria-relation to neurodegeneration. J Neural Transm 118: 349-359.
56. Joseph EK, Levine JD (2006) Mitochondrial electron transport in models of neuropathic and inflammatory pain. Pain 121: 105-114. (Pubitemid 43261637)
57. Richardson DR, Lane DJ, Becker EM, Huang ML, Whitnall M, et al. (2010) Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol. Proc Natl Acad Sci U S A 107: 10775-10782.
58. Carlson ES, Tkac I, Magid R, O'Connor MB, Andrews NC, et al. (2009) Iron is essential for neuron development and memory function in mouse hippocampus. J Nutr 139: 672-679.
59. Moos T, Rosengren Nielsen T (2006) Ferroportin in the postnatal rat brain: implications for axonal transport and neuronal export of iron. Seminars in Pediatric Neurology 13: 149-157. (Pubitemid 44709652)
60. Moos T, Bernth N, Courtois Y, Morgan EH (2011) Developmental iron uptake and axonal transport in the retina of the rat. Mol Cell Neurosci 46: 607-613.
61. Li X, Clark JD (2003) Heme oxygenase type 2 participates in the development of chronic inflammatory and neuropathic pain. Journal of Pain 4: 101-107. (Pubitemid 36337421)
62. Mitchell RM, Lee SY, Randazzo WT, Simmons Z, Connor JR (2009) Influence of HFE variants and cellular iron on monocyte chemoattractant protein-1. J Neuroinflammation 6: 6.
63. Lawless MW, White M, Mankan AK, O'Dwyer MJ, Norris S (2007) Elevated MCP-1 serum levels are associated with the H63D mutation and not the C282Y mutation in hereditary hemochromatosis. Tissue Antigens 70: 294-300. (Pubitemid 47340724)
64. Uceyler N, Rogausch JP, Toyka KV, Sommer C (2007) Differential expression of cytokines in painful and painless neuropathies. Neurology 69: 42-49. (Pubitemid 47025203)
65. Leung L, Cahill CM (2010) TNF-alpha and neuropathic pain - a review. Journal of Neuroinflammation 7: 27.
66. Foulkes T, Wood JN (2008) Pain Genes. Plos Genetics 4: e1000086
67. Tramullas M, Lantero A, Diaz A, Morchon N, Merino D, et al. (2010) BAMBI (bone morphogenetic protein and activin membrane-bound inhibitor) reveals the involvement of the transforming growth factor-beta family in pain modulation. J Neurosci 30: 1502-1511.
68. Wang J, Pantopoulos K (2011) Regulation of cellular iron metabolism. Biochem J 434: 365-381.
69. Calabrese V, Lodi R, Tonon C, D'Agata V, Sapienza M, et al. (2005) Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia. J Neurol Sci 233: 145-162. (Pubitemid 40812334)
70. Stemmler TL, Lesuisse E, Pain D, Dancis A (2010) Frataxin and mitochondrial FeS cluster biogenesis. J Biol Chem 285: 26737-26743.
71. Ye H, Rouault TA (2010) Human iron-sulfur cluster assembly, cellular iron homeostasis, and disease. Biochemistry 49: 4945-4956.
72. Staats KA, Schonefeldt S, Van Rillaer M, Van Hoecke A, Van Damme P, et al. (2013) Beta-2 microglobulin is important for disease progression in a murine model for amyotrophic lateral sclerosis. Front Cell Neurosci 7: 249.
73. Ayton S, Zhang M, Roberts BR, Lam LQ, Lind M, et al. (2014) Ceruloplasmin and beta-amyloid precursor protein confer neuroprotection in traumatic brain injury and lower neuronal iron. Free Radic Biol Med. Feb 7 (Epub ahead of print).
74. Tang WH, Wu Y, Hartiala J, Fan Y, Stewart AF, et al. (2012) Clinical and genetic association of serum ceruloplasmin with cardiovascular risk. Arterioscler Thromb Vasc Biol 32: 516-522.
75. El Boghdady NA, Badr GA (2012) Evaluation of oxidative stress markers and vascular risk factors in patients with diabetic peripheral neuropathy. Cell Biochem Funct 30: 328-334.
76. Tan EC, Bahrami S, Kozlov AV, Kurvers HA, Ter Laak HJ, et al. (2009) The oxidative response in the chronic constriction injury model of neuropathic pain. J Surg Res 152: 84-88.
77. Thaisetthawatkul P, Collazo-Clavell ML, Sarr MG, Norell JE, Dyck PJ (2004) A controlled study of peripheral neuropathy after bariatric surgery. Neurology 63: 1462-1470. (Pubitemid 39426282)
78. Rensvold JW, Ong SE, Jeevananthan A, Carr SA, Mootha VK, et al. (2013) Complementary RNA and Protein Profiling Identifies Iron as a Key Regulator of Mitochondrial Biogenesis. Cell Rep 3: 237-245.
79. Hao S (2013) The Molecular and Pharmacological Mechanisms of HIV-Related Neuropathic Pain. Curr Neuropharmacol 11: 499-512.
80. Li JY, Wang X, Ji PT, Li XF, Guan GH, et al. (2012) Peripheral nerve injury decreases the expression of metabolic glutamate receptor 7 in dorsal root ganglion neurons. Neurosci Lett 531: 52-56.
81. Yan X, Jiang E, Gao M, Weng HR (2013) Endogenous activation of presynaptic NMDA receptors enhances glutamate release from the primary afferents in the spinal dorsal horn in a rat model of neuropathic pain. J Physiol 591: 2001-2019.
82. Mitchell RM, Lee SY, Simmons Z, Connor JR (2011) HFE polymorphisms affect cellular glutamate regulation. Neurobiol Aging 32: 1114-1123.
83. Belfer I, Dai F (2010) Phenotyping and Genotyping Neuropathic Pain. Curr Pain Headache Rep 14: 203-212.
84. Keltner JR, Fennema-Notestine C, Vaida F, Wang D, Franklin DR, et al; for the CHARTER Group (2014) HIV-associated distal neuropathic pain is associated with smaller total cerebral cortical gray matter. J Neurovirol Feb 19 (Epub ahead of print).
85. Ropele S, Wattjes MP, Langkammer C, Kilsdonk ID, de Graaf WL, et al. (2013) Multicenter R2* mapping in the healthy brain. Magn Reson Med May 8 (Epub ahead of print).